A 6-month controlled naltrexone study: Combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependenceBALLDIN, J; BERGLUND, M; WILLANDER, A et al.Alcoholism, clinical and experimental research. 2003, Vol 27, Num 7, pp 1142-1149, issn 0145-6008, 8 p.Article

Pain as a reward: Changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systemsBENEDETTI, Fabrizio; THOEN, Wilma; BLANCHARD, Catherine et al.Pain (Amsterdam). 2013, Vol 154, Num 3, pp 361-367, issn 0304-3959, 7 p.Article

Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboonsKAMINSKI, Barbara J; DUKE, Angela N; WEERTS, Elise M et al.Psychopharmacologia. 2012, Vol 223, Num 1, pp 55-66, issn 0033-3158, 12 p.Article

How cognitive assessment through clinical neurophysiology may help optimize chronic alcoholism treatmentCAMPANELLA, S; PETIT, G; VERBANCK, P et al.Neurophysiologie clinique (Paris). 2011, Vol 41, Num 3, pp 115-123, issn 0987-7053, 9 p.Article

Naltrexone for the management of post-burn pruritus : A preliminary reportLASALLE, L; RACHELSKA, G; NEDELEC, B et al.Burns. 2008, Vol 34, Num 6, pp 797-802, issn 0305-4179, 6 p.Article

Naltrexone's suppressant effects on drinking are limited to the first 3 months of treatmentDAVIDSON, Dena; WIRTZ, Philip W; GULLIVER, Suzy Bird et al.Psychopharmacologia. 2007, Vol 194, Num 1, pp 1-10, issn 0033-3158, 10 p.Article

Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexoneDUNBAR, Joi L; TURNCLIFF, Ryan Z; QUNMING DONG et al.Alcoholism, clinical and experimental research. 2006, Vol 30, Num 3, pp 480-490, issn 0145-6008, 11 p.Article

Naltrexone attenuates acute cigarette smoking behaviorEPSTEIN, Alyssa M; KING, Andrea C.Pharmacology, biochemistry and behavior. 2004, Vol 77, Num 1, pp 29-37, issn 0091-3057, 9 p.Article

Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinkingANTON, Raymond F; DROBES, David J; VORONIN, Konstantin et al.Psychopharmacologia. 2004, Vol 173, Num 1-2, pp 32-40, issn 0033-3158, 9 p.Article

Adverse events in the removal of naltrexone implantsSADLEIR, P. H. M; GARDNER, A. I; HENNESSY, B et al.Anaesthesia and intensive care. 2011, Vol 39, Num 5, pp 895-898, issn 0310-057X, 4 p.Article

Pharmacokinetics and dialysability of naltrexone in patients undergoing hemodialysisKAMBIA, Nicolas K; DINE, Thierry; ODOU, Pascal et al.European journal of drug metabolism and pharmacokinetics. 2004, Vol 29, Num 4, pp 225-230, issn 0378-7966, 6 p.Article

Effect of Extended-Release Naltrexone (XR-NTX) on Quality of Life in Alcohol-Dependent PatientsPETTINATI, Helen M; GASTFRIEND, David R; QUNMING DONG et al.Alcoholism, clinical and experimental research. 2009, Vol 33, Num 2, pp 350-356, issn 0145-6008, 7 p.Article

Risk Factors for Craving and Relapse in Heroin Users Treated with Oral or Implant NaltrexoneHULSE, Gary K; NGO, Hanh T. T; TAIT, Robert J et al.Biological psychiatry (1969). 2010, Vol 68, Num 3, pp 296-302, issn 0006-3223, 7 p.Article

New therapeutic options for alcohol dependence : Long-acting intramuscular formulations of naltrexoneGARBUTT, James C.The Journal of clinical psychiatry. 2006, Vol 67, pp 30-34, issn 0160-6689, 5 p., SUP14Article

Application of the message-address concept to the docking of naltrexone and selective naltrexone-derived opioid antagonists into opioid receptor modelsMETZGER, T. G; GERMANA PATERLINI, M; PORTOGHESE, P. S et al.Neurochemical research. 1996, Vol 21, Num 11, pp 1287-1294, issn 0364-3190Article

Early Treatment Response in Alcohol Dependence With Extended-Release NaltrexoneCIRAULO, Domenic A; QUNMING DONG; SILVERMAN, Bernard L et al.The Journal of clinical psychiatry. 2008, Vol 69, Num 2, pp 190-195, issn 0160-6689, 6 p.Article

An open trial of naltrexone in the treatment of depersonalization disorderSIMEON, Daphne; KNUTELSKA, Margaret.Journal of clinical psychopharmacology. 2005, Vol 25, Num 3, pp 267-270, issn 0271-0749, 4 p.Article

Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophreniaPETRAKIS, Ismene L; O'MALLEY, Stephanie; ROUNSAVILLE, Bruce et al.Psychopharmacologia. 2004, Vol 172, Num 3, pp 291-297, issn 0033-3158, 7 p.Article

Retention in naltrexone implant treatment for opioid dependenceKUNØE, Nikolaj; LOBMAIER, Philipp; VEDERHUS, John Kåre et al.Drug and alcohol dependence. 2010, Vol 111, Num 1-2, pp 166-169, issn 0376-8716, 4 p.Article

Favorable Mortality Profile of Naltrexone Implants for Opiate AddictionSTUART REECE, Albert.Journal of addictive diseases. 2010, Vol 29, Num 1, pp 30-50, issn 1055-0887, 21 p.Article

Naltrexone implant treatment for buprenorphine dependence - Mauritian case seriesJHUGROO, Anil; ELLAYAH, Darmen; NORMAN, Amanda et al.Journal of psychopharmacology (Oxford). 2014, Vol 28, Num 8, pp 800-803, issn 0269-8811, 4 p.Article

Effects of naltrexone on post-abstinence alcohol drinking in C57BL/6NCRL and DBA/2J miceTOMIE, Arthur; AZOGU, Idu; LEI YU et al.Progress in neuro-psychopharmacology & biological psychiatry. 2013, Vol 44, pp 240-247, issn 0278-5846, 8 p.Article

Opioid mechanisms that mediate the palatability of and appetite for salt in sodium replete and deficient statesNA, Elisa S; MORRIS, Michael J; ALAN KIM JOHNSON et al.Physiology & behavior. 2012, Vol 106, Num 2, pp 164-170, issn 0031-9384, 7 p.Article

Naltrexone Selectively Elevates GABAergic Neuroactive Steroid Levels in Heavy Drinkers With the ASP40 Allele of the OPRM1 Gene: A Pilot InvestigationRAY, Lara A; HUTCHISON, Kent E; ASHENHURST, James R et al.Alcoholism, clinical and experimental research. 2010, Vol 34, Num 8, pp 1479-1487, issn 0145-6008, 9 p.Article

Opioid antagonism enhances marijuana's effects in heavy marijuana smokersCOOPER, Ziva D; HANEY, Margaret.Psychopharmacologia. 2010, Vol 211, Num 2, pp 141-148, issn 0033-3158, 8 p.Article